Stryker vs. Johnson & Johnson vs. Zimmer Biomet: How they compare in Q3

Orthopedic

Stryker, Johnson & Johnson and Zimmer Biomet posted their third quarter financial results, along with data on how their orthopedic segments performed.

Here is how their third-quarter finances compare:

 

Stryker 

Total sales: $4.5 billion (+7.7 percent) 

Orthopedics and spine: $1.9 billion (+4.4 percent) 

Hips: $347 million (+5.6 percent)

Knees: $481 million (+9.6 percent)

Johnson & Johnson

Total sales: $23.8 billion (+1.9 percent)

Spine, sports and other: $708 million (+0.3 percent) 

Orthopedic: $2.0 billion (+0.1 percent) 

Hips: $352 million (-0.9 percent)

Knees: $317 million (+0.4 percent)

Zimmer Biomet

Total sales: $1.7 billion (-0.9 percent)

Hips: $468 million (+3.1 percent) 

Knees: $657 million (+1.4 percent)

Sports medicine, extremities, trauma, craniomaxillofacial and thoracic: $409.4 million (-6.4 percent)

Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Podcast

Featured Whitepapers